Small Cap IR - Empowering the Age of Genetic Enlightenment

NEW YORK, June 30, 2015 /PRNewswire/ – Small Cap IR issues report. Recently, Arrayit Corporation ARYC had an agreement to supply custom Arrayit blood card technology to Vivos' Global Genome Vault, the only private human DNA vault on earth. Vivos offers an impervious, impenetrable and permanent DNA storage vault, able to provide virtually every man, woman and child on Earth, a safe and secure nuclear blast-proof, underground shelter to store their DNA. Arrayit blood cards allow the rapid collection, separation, drying and storage of human genomic DNA in a format that is permanent and highly miniaturized.

Volume has increased dramatically since the agreement with Vivos' Global Genome Vault and price per share has yet to find a trading range. In the last five trading sessions hitting a low of $0.0035 and a high of $0.007.

To gain a better understanding of the recent events read the analyst brief. The analyst brief can be viewed in its entirety by using the link below. There is no cost obligation required to view this report.

http://bit.ly/_ARYC_AnalystReport
Copy and paste to browser may be required.

About Arrayit Corporation

Arrayit Corporation ARYC leads and empowers the genetic, research, pharmaceutical, and diagnostic communities through the discovery, development and manufacture of proprietary life science technologies and consumables for disease prevention, treatment and cure. It offers its tools and services to genomic research centers, pharmaceutical companies, academic institutions, clinical research organizations, government agencies, and biotechnology companies.

About Small Cap IR

We make the connection between sophisticated investors and high quality micro - small cap companies. We are an issuer of reports written by research analysts who provide an educated opinion of the profiled company. They include stocks traded in the NYSE, NASDAQ, and OTCBB exchanges. For more information and services provided beyond this release please use contact information provided below.

FORWARD-LOOKING DISCLAIMER   

This report may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of mentioned company to be materially different from the statements made herein.  

COMPLIANCE PROCEDURE   

Content is researched, written and reviewed on a best-effort basis. This report was prepared for informational purposes only.  A full disclaimer can be found by viewing the full analyst report. This document, article or report is written and authored by a 3rd party research analyst. However, we are only human and make mistakes. If you notice any errors or omissions, please notify us below.

Contact: admin@smallcapir.com

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/small-cap-ir---empowering-the-age-of-genetic-enlightenment-300106611.html

SOURCE Small Cap IR